Document Detail

Tumorigenic effect of some commonly used moisturizing creams when applied topically to UVB-pretreated high-risk mice.
MedLine Citation:
PMID:  18704106     Owner:  NLM     Status:  MEDLINE    
Irradiation of SKH-1 mice with UVB (30 mJ cm(-2)) twice a week for 20 weeks resulted in mice with a high risk of developing skin tumors over the next several months in the absence of further irradiation with UVB (high-risk mice). Topical applications of 100 mg of Dermabase, Dermovan, Eucerin Original Moisturizing Cream (Eucerin), or Vanicream once a day, 5 days a week for 17 weeks to these high-risk mice increased significantly the rate of formation of tumors and the rate of increase in tumor size per mouse. Additional studies indicated that treatment of high-risk mice with Dermabase, Dermovan, Eucerin, or Vanicream for 17 weeks increased the total number of histologically characterized tumors by 69% (average of two experiments; P<0.0001 in each experiment), 95% (P<0.0001), 24% (P<0.01), and 58% (P<0.0001), respectively. Topical applications of a specially designed Custom Blend cream to high-risk mice was not tumorigenic. The results indicate that several commercially available moisturizing creams increase the rate of formation and number of tumors when applied topically to UVB-pretreated high-risk mice. Further studies are needed to determine the effects of topical applications of moisturizing creams on sunlight-induced skin cancer in humans.
Yao-Ping Lu; You-Rong Lou; Jian-Guo Xie; Qingyun Peng; Weichung J Shih; Yong Lin; Allan H Conney
Related Documents :
23210436 - Effects of arsenic trioxide (as(2)o(3)) on airway remodeling in a murine model of bronc...
19921486 - Extramedullary hematopoiesis is dysregulated in histamine-free histidine decarboxylase ...
1689286 - Effect of recombinant human granulocyte colony-stimulating factor on granulocytopenia i...
21368746 - Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced ...
2386936 - Augmentation of cytotoxic effect of tumor necrosis factor on human immunodeficiency vir...
18679156 - Insights into parturition biology from genetically altered mice.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2008-08-14
Journal Detail:
Title:  The Journal of investigative dermatology     Volume:  129     ISSN:  1523-1747     ISO Abbreviation:  J. Invest. Dermatol.     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-01-16     Completed Date:  2009-02-27     Revised Date:  2014-09-12    
Medline Journal Info:
Nlm Unique ID:  0426720     Medline TA:  J Invest Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  468-75     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Topical
Emollients / pharmacology*
Lipids / pharmacology
Mice, Hairless
Risk Factors
Skin Neoplasms / epidemiology,  etiology*
Sunlight / adverse effects
Ultraviolet Rays / adverse effects*
Water / pharmacology
Grant Support
R01 CA114442/CA/NCI NIH HHS; R01 CA114442/CA/NCI NIH HHS; R01 CA114442-03/CA/NCI NIH HHS
Reg. No./Substance:
0/Emollients; 0/Lipids; 059QF0KO0R/Water; 8036-49-5/eucerin
Comment In:
J Invest Dermatol. 2009 Feb;129(2):515-6; author reply 517-8   [PMID:  19148221 ]
J Invest Dermatol. 2009 Sep;129(9):2316-8; author reply 2318-21   [PMID:  19809425 ]
J Invest Dermatol. 2009 Feb;129(2):513-4; author reply 514-5   [PMID:  19148219 ]
J Invest Dermatol. 2009 Feb;129(2):261-2   [PMID:  19148213 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Topical peroxisome proliferator activated receptor activators accelerate postnatal stratum corneum a...
Next Document:  Development of an IgG4-based predictor of endemic pemphigus foliaceus (fogo selvagem).